Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

TQH-2722

Catalog No. T9901A-1587 Copy Product Info
🥰Excellent
TQH-2722 is a humanized IgG4 monoclonal antibody targeting the IL-4Rα receptor in humans. It effectively blocks the interaction between IL-4Rα and downstream cytokines IL-4 and IL-13, thereby inhibiting inflammatory responses. TQH-2722 is used in research for atopic dermatitis and chronic rhinosinusitis with nasal polyps (CRSwNP).

TQH-2722

Copy Product Info
🥰Excellent
Catalog No. T9901A-1587

TQH-2722 is a humanized IgG4 monoclonal antibody targeting the IL-4Rα receptor in humans. It effectively blocks the interaction between IL-4Rα and downstream cytokines IL-4 and IL-13, thereby inhibiting inflammatory responses. TQH-2722 is used in research for atopic dermatitis and chronic rhinosinusitis with nasal polyps (CRSwNP).

TQH-2722
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
TQH-2722 is a humanized IgG4 monoclonal antibody targeting the IL-4Rα receptor in humans. It effectively blocks the interaction between IL-4Rα and downstream cytokines IL-4 and IL-13, thereby inhibiting inflammatory responses. TQH-2722 is used in research for atopic dermatitis and chronic rhinosinusitis with nasal polyps (CRSwNP).
Chemical Properties
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy TQH-2722 | purchase TQH-2722 | TQH-2722 cost | order TQH-2722